Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

VIIV HLTHCARE

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 25
  • 0 comments

FDA approve DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE

Comment Full text

VIIV HLTHCARE

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 28
  • 0 comments

FDA approve ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

Comment Full text

VIIV HLTHCARE

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 26
  • 0 comments

FDA approve DOLUTEGRAVIR SODIUM

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 25
  • 0 comments

FDA approve NIFEDIPINE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 25
  • 0 comments

FDA approve CARBAMAZEPINE

Comment Full text

AJANTA PHARMA LTD

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 27
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM; NAPROXEN

Comment Full text

XIROMED

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 27
  • 0 comments

FDA approve NAFTIFINE HYDROCHLORIDE

Comment Full text

NOVO

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 22
  • 0 comments

FDA approve SEMAGLUTIDE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 21
  • 0 comments

FDA approve LURASIDONE HYDROCHLORIDE

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Oct. 10, 2022, 01:37 UTC
  • 27
  • 0 comments

FDA approve BIMATOPROST

Comment Full text
  • Previous
  • 970
  • 971
  • 972
  • 973
  • 974
  • Next

Search

News categories

  • Technical Exchange News(12342)
  • Event(6229)
  • SEC News(270139)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(157444)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin